Tokyo Tape
Sign in
← Torii Pharmaceutical

Annual report

4551.TEDINET S100T4CW
Period2023-01-01 → 2023-12-31
Filed2024-03-27
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 89
MetricValuePeriodScopeSource row
Revenue¥54.6bn2023-01-01 → 2023-12-31StandaloneNet sales
Revenue¥48.9bn2022-01-01 → 2022-12-31StandaloneNet sales
Revenue¥47.0bn2021-01-01 → 2021-12-31dStandaloneNet sales (5-year summary)
Revenue¥41.7bn2020-01-01 → 2020-12-31dStandaloneNet sales (5-year summary)
Revenue¥43.0bn2019-01-01 → 2019-12-31dStandaloneNet sales (5-year summary)
Operating income¥5.0bn2023-01-01 → 2023-12-31StandaloneOperating income
Operating income¥5.5bn2022-01-01 → 2022-12-31StandaloneOperating income
Ordinary income¥5.3bn2023-01-01 → 2023-12-31StandaloneOrdinary income
Ordinary income¥5.5bn2022-01-01 → 2022-12-31StandaloneOrdinary income
Ordinary income¥4.8bn2021-01-01 → 2021-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥5.0bn2020-01-01 → 2020-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥1.7bn2019-01-01 → 2019-12-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥5.6bn2023-01-01 → 2023-12-31StandaloneIncome before income taxes
Profit before tax¥5.7bn2022-01-01 → 2022-12-31StandaloneIncome before income taxes
Net income¥4.1bn2023-01-01 → 2023-12-31StandaloneProfit loss
Net income¥3.9bn2022-01-01 → 2022-12-31StandaloneProfit loss
Net income¥3.4bn2021-01-01 → 2021-12-31dStandaloneNet income loss (5-year summary)
Net income¥3.5bn2020-01-01 → 2020-12-31dStandaloneNet income loss (5-year summary)
Net income¥27.4bn2019-01-01 → 2019-12-31dStandaloneNet income loss (5-year summary)
Total assets¥133.4bnat 2023-12-31StandaloneAssets
Total assets¥133.7bnat 2022-12-31StandaloneAssets
Total assets¥130.8bnat 2021-12-31dStandaloneTotal assets (5-year summary)
Total assets¥126.0bnat 2020-12-31dStandaloneTotal assets (5-year summary)
Total assets¥139.9bnat 2019-12-31dStandaloneTotal assets (5-year summary)
Total liabilities¥13.3bnat 2023-12-31StandaloneLiabilities
Total liabilities¥14.5bnat 2022-12-31StandaloneLiabilities
Net assets / equity¥120.1bnat 2023-12-31StandaloneNet assets
Net assets / equity¥119.2bnat 2022-12-31StandaloneNet assets
Net assets / equity¥117.0bnat 2021-12-31dStandaloneNet assets
Net assets / equity¥115.1bnat 2020-12-31dStandaloneNet assets (5-year summary)
Net assets / equity¥113.1bnat 2019-12-31dStandaloneNet assets (5-year summary)
Cash and deposits¥5.0bnat 2023-12-31StandaloneCash and deposits
Cash and deposits¥9.2bnat 2022-12-31StandaloneCash and deposits
Cash & equivalents¥34.7bnat 2023-12-31StandaloneCash and cash equivalents
Cash & equivalents¥45.4bnat 2022-12-31StandaloneCash and cash equivalents
Cash & equivalents¥58.4bnat 2021-12-31dStandaloneCash and cash equivalents
Cash & equivalents¥61.6bnat 2020-12-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥58.8bnat 2019-12-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow−¥3.1bn2023-01-01 → 2023-12-31StandaloneNet cash provided by used in operating activities
Operating cash flow¥2.4bn2022-01-01 → 2022-12-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥156m2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥3.4bn2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥42.5bn2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥3.8bn2023-01-01 → 2023-12-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥13.7bn2022-01-01 → 2022-12-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥1.5bn2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow¥7.6bn2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow¥2.1bn2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow−¥3.8bn2023-01-01 → 2023-12-31StandaloneNet cash provided by used in financing activities
Financing cash flow−¥1.7bn2022-01-01 → 2022-12-31StandaloneNet cash provided by used in financing activities
Financing cash flow−¥1.5bn2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow−¥1.4bn2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow−¥1.4bn2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥146.62023-01-01 → 2023-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥140.392022-01-01 → 2022-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥120.132021-01-01 → 2021-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥124.472020-01-01 → 2020-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥974.982019-01-01 → 2019-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥124.462020-01-01 → 2020-12-31dStandaloneDiluted earnings per share (5-year summary)
Dividend per share¥1202023-01-01 → 2023-12-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥1002022-01-01 → 2022-12-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥482021-01-01 → 2021-12-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥482020-01-01 → 2020-12-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥482019-01-01 → 2019-12-31dStandaloneDividend paid per share (5-year summary)
Net assets per share¥4,274.45at 2023-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥4,243.08at 2022-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥4,165.38at 2021-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥4,097.55at 2020-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥4,029.3at 2019-12-31dStandaloneNet assets per share (5-year summary)
Equity ratio90.0%at 2023-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio89.2%at 2022-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio89.5%at 2021-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio91.3%at 2020-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio80.8%at 2019-12-31dStandaloneEquity to asset ratio (5-year summary)
ROE3.4%2023-01-01 → 2023-12-31StandaloneRate of return on equity (5-year summary)
ROE3.3%2022-01-01 → 2022-12-31StandaloneRate of return on equity (5-year summary)
ROE2.9%2021-01-01 → 2021-12-31dStandaloneRate of return on equity (5-year summary)
ROE3.1%2020-01-01 → 2020-12-31dStandaloneRate of return on equity (5-year summary)
ROE27.3%2019-01-01 → 2019-12-31dStandaloneRate of return on equity (5-year summary)
Shares issued28,800,000at 2023-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued28,800,000at 2022-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued28,800,000at 2021-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued28,800,000at 2020-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued28,800,000at 2019-12-31dStandaloneTotal number of issued shares (5-year summary)
Employees583at 2023-12-31StandaloneNumber of employees
Employees563at 2022-12-31StandaloneNumber of employees
Employees560at 2021-12-31dStandaloneNumber of employees
Employees568at 2020-12-31dStandaloneNumber of employees
Employees660at 2019-12-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 1
SegmentItemPeriodValue
Pharmaceutical Businessreportable segmentemployeesat 2023-12-31583 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 949
ItemContextValueUnit
Current liabilitiesCurrentYearInstant_NonConsolidatedMember12504000000JPY
Lease obligations nclPrior1YearInstant_NonConsolidatedMember241000000JPY
Lease obligations nclCurrentYearInstant_NonConsolidatedMember22000000JPY
Provision for retirement benefitsPrior1YearInstant_NonConsolidatedMember707000000JPY
Provision for retirement benefitsCurrentYearInstant_NonConsolidatedMember478000000JPY
Asset retirement obligations nclPrior1YearInstant_NonConsolidatedMember54000000JPY
Asset retirement obligations nclCurrentYearInstant_NonConsolidatedMember54000000JPY
Other nclPrior1YearInstant_NonConsolidatedMember239000000JPY
Other nclCurrentYearInstant_NonConsolidatedMember239000000JPY
Noncurrent liabilitiesPrior1YearInstant_NonConsolidatedMember1242000000JPY
Noncurrent liabilitiesCurrentYearInstant_NonConsolidatedMember794000000JPY
LiabilitiesPrior1YearInstant_NonConsolidatedMember14464000000JPY
LiabilitiesCurrentYearInstant_NonConsolidatedMember13298000000JPY
Capital stockPrior1YearInstant_NonConsolidatedMember5190000000JPY
Capital stockCurrentYearInstant_NonConsolidatedMember5190000000JPY
Legal capital surplusPrior1YearInstant_NonConsolidatedMember6416000000JPY
Legal capital surplusCurrentYearInstant_NonConsolidatedMember6416000000JPY
Other capital surplusPrior1YearInstant_NonConsolidatedMember37000000JPY
Other capital surplusCurrentYearInstant_NonConsolidatedMember44000000JPY
Capital surplusPrior1YearInstant_NonConsolidatedMember6453000000JPY
Capital surplusCurrentYearInstant_NonConsolidatedMember6460000000JPY
Legal retained earningsPrior1YearInstant_NonConsolidatedMember1297000000JPY
Legal retained earningsCurrentYearInstant_NonConsolidatedMember1297000000JPY
General reservePrior1YearInstant_NonConsolidatedMember56130000000JPY
General reserveCurrentYearInstant_NonConsolidatedMember56130000000JPY
Retained earnings brought forwardPrior1YearInstant_NonConsolidatedMember51418000000JPY
Retained earnings brought forwardCurrentYearInstant_NonConsolidatedMember51997000000JPY
Retained earningsPrior1YearInstant_NonConsolidatedMember108846000000JPY
Retained earningsCurrentYearInstant_NonConsolidatedMember109425000000JPY
Treasury stockPrior1YearInstant_NonConsolidatedMember-1381000000JPY
Treasury stockCurrentYearInstant_NonConsolidatedMember-1369000000JPY
Shareholders equityPrior1YearInstant_NonConsolidatedMember119107000000JPY
Shareholders equityCurrentYearInstant_NonConsolidatedMember119706000000JPY
Valuation difference on available for sale securitiesPrior1YearInstant_NonConsolidatedMember117000000JPY
Valuation difference on available for sale securitiesCurrentYearInstant_NonConsolidatedMember427000000JPY
Valuation and translation adjustmentsPrior1YearInstant_NonConsolidatedMember117000000JPY
Valuation and translation adjustmentsCurrentYearInstant_NonConsolidatedMember427000000JPY
Net assetsPrior1YearInstant_NonConsolidatedMember119224000000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember120134000000JPY
Liabilities and net assetsPrior1YearInstant_NonConsolidatedMember133689000000JPY
Liabilities and net assetsCurrentYearInstant_NonConsolidatedMember133432000000JPY
Net sales of goods rev oaPrior1YearDuration_NonConsolidatedMember22629000000JPY
Net sales of goods rev oaCurrentYearDuration_NonConsolidatedMember24960000000JPY
Net sales of finished goods rev oaPrior1YearDuration_NonConsolidatedMember25933000000JPY
Net sales of finished goods rev oaCurrentYearDuration_NonConsolidatedMember29378000000JPY
Other sales rev oaPrior1YearDuration_NonConsolidatedMember332000000JPY
Other sales rev oaCurrentYearDuration_NonConsolidatedMember299000000JPY
Net salesPrior1YearDuration_NonConsolidatedMember48896000000JPY
Net salesCurrentYearDuration_NonConsolidatedMember54638000000JPY
Beginning merchandise and finished goods cosPrior1YearDuration_NonConsolidatedMember5542000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 13 of 13 passed
balance sheet identitynon_consolidated 2022-12-31pass rounding
balance sheet identitynon_consolidated 2023-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2021-12-31pass
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · net assetsnon_consolidated 2023-12-31pass
statement vs summary · operating cash flownon_consolidated 2022-01-01/2022-12-31pass
statement vs summary · operating cash flownon_consolidated 2023-01-01/2023-12-31pass
statement vs summary · revenuenon_consolidated 2022-01-01/2022-12-31pass
statement vs summary · revenuenon_consolidated 2023-01-01/2023-12-31pass
statement vs summary · total assetsnon_consolidated 2022-12-31pass
statement vs summary · total assetsnon_consolidated 2023-12-31pass